Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kyllikki Haapala"'
Publikováno v:
Clinical Genetics. 24:50-53
A complex and unique, apparently balanced translocation involving No. 1 long arm and No. 10 short and long arm, segregated in a family and produced an unbalanced progeny with recombination of t(10) translocation chromosome during paternal meiosis.
Autor:
Pasi A. Koivisto, Marita Laurila, Eija-R. Hyytinen, Kyllikki Haapala, Mikko Roiha, Heikki Helin, Immo Rantala
Publikováno v:
Laboratory Investigation. 81:1647-1651
Mechanisms of prostate cancer (CaP) recurrence during a combined androgen blockade (CAB) are poorly understood. Previously, the role of androgen receptor (AR) gene mutations underlying the CAB therapy relapse has been raised. To investigate the hypot
Autor:
Pasi A. Koivisto, Kyllikki Haapala, E. Hyytinen, Tuula Kuukasjärvi, Heikki Helin, Immo Rantala
Publikováno v:
Human pathology. 38(3)
Mechanisms of prostate cancer progression during hormonal therapy and the pathobiologic consequences of androgen receptor (AR) gene amplification are inadequately known. To further investigate the hypothesis that AR gene amplification is associated w
Autor:
Immo Rantala, Eija-Riitta Hyytinen, Kyllikki Haapala, Heikki Helin, Olli A. Jänne, James Thompson, Pasi A. Koivisto, Jorma J. Palvimo
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 83(12)
Androgen action is mediated through androgen receptor (AR), which appears to undergo structural and functional alterations during prostate cancer (CaP) progression. AR mutations have been infrequently reported in CaP before hormonal therapy, but in u
Autor:
Mauno Vihinen, Heikki Helin, Kyllikki Haapala, Ilkka Lappalainen, James Thompson, Mikko Roiha, Immo Rantala, Olli A. Jänne, Eija-R. Hyytinen, Pasi A. Koivisto, Jorma J. Palvimo
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 82(11)
Progression to hormone-refractory growth of prostate cancer has been suggested to be mediated by androgen receptor (AR) gene alterations. We analyzed AR for mutations and amplifications in 21 locally recurrent prostate carcinomas treated with orchiec
Autor:
Pasi A. Koivisto, Teuvo L.J. Tammela, C. Palmberg, Marita Laurila, Kyllikki Haapala, E. Hyytinen, Annika Rökman
Publikováno v:
Cancer genetics and cytogenetics. 131(1)
The genetic mechanisms of prostate cancer recurrence during hormonal therapy are largely unknown. So far, data from conventional karyotype analysis on hormone-refractory prostate carcinomas have not been published, mainly because of the difficulties
Publikováno v:
Clinical Dysmorphology. 5:139
We report a rare chromosomal finding in a boy with a pronounced scalp defect, dysmorphic features and mental retardation. Initially, what seemed to be a normal karyotype by conventional karyotyping was determined to be a de novo deletion involving 15